PREVIOUS studies (Fink et al., 1965; Joannides, Rosner and Lee, 1968; Bates, Bankole and Swaim, 1969) reported that blood cells from patients with Hodgkin's disease, multiple myeloma, and other lymphomata fluoresced when reacted with antimurine leukaemia virus (Rauscher) or antihuman leukaemia plasma antiserum. In another report (Swaim et al., 1971 ) the onset of myelogenous leukaemia in a patient with Hodgkin's disease was characterized by the appearance of nucleated peripheral blood cells which fluoresced when reacted with the above described leukaemia antiserum.
The following study was directed towards determining: (1) the antigens involved in fluorescence by peripheral blood cells from Hodgkin's disease, multiple myeloma and lymphosarcoma patients, (2) whether this fluorescence was variable or continuous over a period of time, and (3) the relationship between cellular fluorescence and patient's clinical state.
MATERIALS AND METHODS

Preparation of antiserum
Preparation, conjugation and tissue absorption of leukaemia virus (Rauscher) monkey antiserum (AMR)* and rabbit antisera against human stem cell leukaemia plasma pellet (AHS) were carried out as described previously (Bates et al., 1969) .
Leukocyte absorption and immunological specificity
Leukocytes from 30 individuals with normal blood cell morphology and counts were pooled and triturated on a Ten Broeck grinder. To this material was added an equal volume of phosphate (0-10 mol/l) buffered saline (0a15 mol/1) pH 7-2 (PBS). To 2 ml of conjugated serum (AMR or AHS) was added 0-2 ml of the cellular extract. This mixture was reacted at 37°C for 2 hours with occasional shaking and then centrifuged at 5000 g for 60 min.
The supernatant was removed and reacted, as described below with the leukocytes studied. Immunological specificity was determined by methods described previously (Bates, et al., 1969 (Bohlool and Schmidt, 1968) mixed with an equal volume Nor Cars of AMR or AHS. After staining, the specimen was washed in phosphate buffer pH 7-6, 0 01 mol/l, air dried and mounted just prior to examination in buffered glycerol (9 parts glycerol, 1 part phosphate buffer pH 7-8, 0-02 mol/l). A Leitz microscope with an u.v. barrier filter was used to examine the smears. Cells were observed with a 54 x oil immersion objective lens. Depending on the number of cells present, 100-1000 nucleated cells were studied and the intensity of cytoplasmic fluorescence graded as non-reactive (NR), weakly reactive (WR), reactive (R) or strongly reactive (SR). For each specimen 4 slides were prepared and reacted with AMR and AHS. Nuclear fluorescence was rarely observed. If 5% or more of the total observed nucleated cells in the 4 slides were R to SR, immunofluorescence was considered significant. The 5% value was determined after observing that normal blood specimens showed 0 to 2% of their cells R with absorbed AMR and AHS. When specimens obtained from a patient at different time intervals were R to SR and the percentage of cells with fluorescence in the respective specimens varied more than + 14% (2 S.D.), this was considered significant fluorescent variation. The technical variation for this study was determined on cells from a patient with myelogenous leukaemia. Twenty-five blood smears were prepared from one blood specimen and the number of cells/100 nucleated cells showing significant cytoplasmic fluorescence determined. The range was 21 to 28 with a mean positive fluorescence cell count of 24 + 7% (1 S.D.). After 2 absorptions of AMR and AHS with pooled W.B.C., nucleated peripheral blood cells from the controls (Table I) were NR to both AMR and AHS, and the multiple myeloma and Hodgkin's lymphosarcoma cases were R to SR (Fig. 1) . When nucleated blood cells from the latter cases were first reacted with absorbed unconjugated AMR or AHS, and then absorbed conjugated AMR or AHS, fluorescence was NR to WAR. Pretreatment with normal rabbit or human plasma did not " block " fluorescence by these cells.
Nine of 10 multiple myeloma, 7 of 10 Hodgkin's and 9 of 11 lymphosarcoma cases listed in Table I had significant fluorescence with both AMR and AHS or AHS but never AMR alone.
Significant fluorescent cell count variations occurred in 7 of 10 multiple myeloma, 5 of 10 Hodgkin's and 9 of 11 lymphosarcoma cases. All of these cases were males under treatment, whose diseases were diagnosed prior to this study.
The carcinoma cases listed in Table I Since not all normal leukocyte isoantigens are known, interpretation of these data is difficult. One cytotoxicity study (Peacocke et al., 1966) showed that chronic lymphatic leukaemic cells contained normal leukocyte isoantigens with normal or above normal frequency. In our study, repeated absorption of AMR and AHS with normal leukocytes resulted in the following progressive reduction in cytoplasmic fluorescent activity (normals, carcinomata, infectious mononucleosis, Hodgkin's, lymphosarcoma, myelogenous leukaemia).
Biophysical reactions associated with absorption could account for some loss of fluorescent activity. However, its progressive loss indicated that these cells contained different concentrations of the antigen(s) being detected. The significance of this antigen(s) in respect to aetiology of these diseases is not known.
As in human leukaemia (Fink et al., 1965; Yohn et al., 1968 ) a viral aetiology was considered. In our study, absorption of AMR with normal human leukocytes reduced its fluorescent activity. The presence in human leukocytes of Rauscher virus antigenic determinants wasdifficult to comprehend.
One explanation was that the preparation of leukocytes for absorption, altered or exposed " masked " leukocyte antigens common to this virus.
This offered an explanation for absorption results but failed to explain why the concentration of this antigen(s) increased in active states of the described diseases.
WAe postulated that the presence of this antigen(s) indicated a cellular disorder with a common metabolic pathway. Whether this pathway was viral, drug, or radiation induced remains unanswered.
Serial studies on described cases showed a variation in fluorescent intensity and percentage of cells positive. This variation was also observed in our leukaemia study Bates et al., 1969) .
In the latter study the presence of fluorescing peripheral blood cells correlated with haematological parameters indicative of active leukaemia. Although no correlation with haematological findings was evident in the present study, a relationship existed between active disease and the presence of fluorescing cells. The aetiological significance of these findings was discussed.
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